NCT06954688

Brief Summary

Spinal cord injury is a life-changing event that places a burden on the healthcare system, including caregivers and affected individuals. Studies do not provide a conclusive incidence rate due to methodological differences. However, a trend observed in recent years is an increasing incidence among the elderly population due to falls or non-traumatic spinal cord injury. The clinical consequences of spinal cord injury include pain and spasticity, in addition to loss of function and activity. On average, 69% of spinal cord injury patients report pain, with one-third experiencing severe pain. A similar prevalence is seen for spasticity, which is often underreported among spinal cord injury patients. Unlike pain, spasticity is considered a common symptom in chronic spinal cord injury, with at least 35% of the SCI population suffering from this sensorimotor control disorder. These two symptoms suggest a correlation, yet clear evidence is lacking. The secondary aim of this study is to explain the mechanisms of action of Dry Needling at various levels to better determine which subgroup of spinal cord injury patients would benefit most. A targeted study could optimize the effects of such a treatment: a better understanding of the underlying mechanisms could help with patient stratification and promote a more individualized approach, taking into account the pathogenesis of spasticity and the different mechanisms that can effectively modulate it. Additionally, this study examines the effect of the dry needling technique on hypertonia and spasticity in the spastic calf muscles of spinal cord injury patients. Research has already shown that this technique has acute effects on hypertonia and spasticity in stroke, multiple sclerosis, and Parkinson's disease. However, reliable research on spinal cord injury is lacking-currently, only a case report has investigated these effects. Therefore, this study is well-suited to build upon that case report and provide more evidence. Furthermore, this study serves as a prospective study to observe the correlation between neuropathic pain and spasticity over time. As a pilot study, it has established a collaboration with the REVARTE rehabilitation hospital, which has a large spinal cord injury population. The research will be conducted under the supervision of Prof. Dr. Steven Truijen (Universiteitsplein 1, 2610 Wilrijk, Belgium, steven.truijen@uantwerpen.be) and Prof. Dr. Wim Saeys (Universiteitsplein 1, 2610 Wilrijk, Belgium, wim.saeys@uantwerpen.be), organized from the University of Antwerp. During this study, no research costs will be charged to the patient, health insurance, or research environment. Thank you in advance for your attention to our research.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 31, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 1, 2025

Completed
Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

March 31, 2025

Last Update Submit

April 24, 2025

Conditions

Keywords

spinal cord injurypainspasticitydry needling

Outcome Measures

Primary Outcomes (3)

  • DN4 Questionnaire:

    This questionnaire consists of ten items (four questions) on a total score of ten points. It has a cut-off of four points to identify the reported pain as neuropathic. The DN4 Questionnaire has been identified as a reliable and sensitive assessment for neuropathic pain

    At week 1(beginning of the study, pre-intervention period) , week 4 (mid-study) and week 8 (end of the study, post-intervention period)

  • PainDetect Questionnaire(PD-Q)

    This questionnaire has been included to monitor pain severity and/or its time-dependent course17. It is a more extensive questionnaire In comparison to the DN4 Questionnaire despite having a lower sensitivity than the latter in SCI populationn16. Still, the PD-Q was chosen over the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) because of the difference between sensitivity (PD-Q 68% versus LANSS 36%).

    At week 1(beginning of the study, pre-intervention period) , week 4 (mid-study) and week 8 (end of the study, post-intervention period)

  • The International Spinal Cord Injury Pain (ISCIP) Classification:

    This classification fits as a valid assessment that is comprehensive and feasible in use for experienced as well as non-experiences clinicians and includes all types of pain related to Spinal Cord Injury.

    Twice: Pre-intervention period (week 1) and post-intervention period (week 8)

Secondary Outcomes (5)

  • Modified Tardieu Scale

    Every week (week1 to week 8)

  • ASIA scale

    Twice: Pre-intervention period (week 1) and post-intervention period (week 8)

  • Spinal Cord Independence Measure (SCIM)

    At week 1(beginning of the study, pre-intervention period) , week 4 (mid-study) and week 8 (end of the study, post-intervention period)

  • Two minute walk test

    At week 1(beginning of the study, pre-intervention period) , week 4 (mid-study) and week 8 (end of the study, post-intervention period)

  • Quality of Life Questionaire(Sci-QoL)

    At week 1(beginning of the study, pre-intervention period) , week 4 (mid-study) and week 8 (end of the study, post-intervention period)

Study Arms (1)

dry needling

EXPERIMENTAL

dry needling

Other: dry needling

Interventions

Dry Needling: The puncture is intramuscular and is performed with a non-beveled, filiform, solid needle, similar to those used in acupuncture, which has been shown to produce less damage at the muscle level. It does not infiltrate any substance. As many entries as necessary are made until the local twitch response (LTR) is exhausted.

dry needling

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spinal Cord Injury with ASIA impairment scale of B, C or D
  • Age between 18 and 85 years
  • Minimal spasticity (TDS \>1) in the ankle flexors.

You may not qualify if:

  • ASIA impairment scale A or E
  • severe co-existent other systemic injuries
  • concomitant head injury
  • Glasgow coma scale score \<15
  • non-cooperative patient
  • No informed consent given

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation sciences and physiotherapy (MOVANT)

Antwerp, Antwerpen, 2020 Antwerpen, Belgium

Location

MeSH Terms

Conditions

NeuralgiaMuscle SpasticitySpinal Cord InjuriesPain

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: monocentric interventional cohort study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, PhD

Study Record Dates

First Submitted

March 31, 2025

First Posted

May 1, 2025

Study Start

September 6, 2024

Primary Completion

February 4, 2025

Study Completion

February 4, 2025

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Data is stored on the online data storage and colllection database (REDCAP). Database is available for institutions writing a formal letter to our contact person. This change in GDPR informed consent description will be asked to the participated patients to share demanded data.

Locations